[go: up one dir, main page]

WO2014057407A3 - Compositions and methods for treatment of diabetes and prediabetes - Google Patents

Compositions and methods for treatment of diabetes and prediabetes Download PDF

Info

Publication number
WO2014057407A3
WO2014057407A3 PCT/IB2013/059146 IB2013059146W WO2014057407A3 WO 2014057407 A3 WO2014057407 A3 WO 2014057407A3 IB 2013059146 W IB2013059146 W IB 2013059146W WO 2014057407 A3 WO2014057407 A3 WO 2014057407A3
Authority
WO
WIPO (PCT)
Prior art keywords
diabetes
compositions
prediabetes
treatment
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2013/059146
Other languages
French (fr)
Other versions
WO2014057407A2 (en
Inventor
Mahesh Kandula
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of WO2014057407A2 publication Critical patent/WO2014057407A2/en
Publication of WO2014057407A3 publication Critical patent/WO2014057407A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/207—Cyclohexane rings not substituted by nitrogen atoms, e.g. kasugamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The compounds of formula (I) or its pharmaceutically acceptable salts, as well as polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of formula (I) maybe used for treating metabolic syndrome, insulin resistance, glucose intolerance, hyperinsulinemia, diabetes mellitus, diabetes, insipidus, hyperglycemia and diabetic complications.
PCT/IB2013/059146 2012-10-12 2013-10-06 Compositions and methods for the treatment of diabetes and prediabetes Ceased WO2014057407A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN4282CH2012 2012-10-12
IN4282/CHE/2012 2012-10-12

Publications (2)

Publication Number Publication Date
WO2014057407A2 WO2014057407A2 (en) 2014-04-17
WO2014057407A3 true WO2014057407A3 (en) 2014-06-26

Family

ID=50478007

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2013/059146 Ceased WO2014057407A2 (en) 2012-10-12 2013-10-06 Compositions and methods for the treatment of diabetes and prediabetes

Country Status (1)

Country Link
WO (1) WO2014057407A2 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102140485A (en) * 2010-12-25 2011-08-03 浙江工业大学 Method for preparing acarbose through microbial fermentation
WO2011117749A1 (en) * 2010-03-23 2011-09-29 Mahesh Kandula Compound and method for the treatment of pain
US20110300190A1 (en) * 2010-06-08 2011-12-08 Krisani Biosciences (P) Ltd Compound, composition and uses thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011117749A1 (en) * 2010-03-23 2011-09-29 Mahesh Kandula Compound and method for the treatment of pain
US20110300190A1 (en) * 2010-06-08 2011-12-08 Krisani Biosciences (P) Ltd Compound, composition and uses thereof
CN102140485A (en) * 2010-12-25 2011-08-03 浙江工业大学 Method for preparing acarbose through microbial fermentation

Also Published As

Publication number Publication date
WO2014057407A2 (en) 2014-04-17

Similar Documents

Publication Publication Date Title
WO2009010416A3 (en) Inhibitors of 11b-hydroxysteroid dehydrogenase
TN2012000152A1 (en) Spiropiperidine compounds and pharmaceutical use thereof for treating diabetes
PL2133091T3 (en) Compositions comprising supramolecular insulin assemblies useful for the treatment of diabetes
WO2007107470A3 (en) Pyrazoles as 11-beta-hsd-1
NZ598085A (en) Methods, compounds, and compositions for delivering 1,3-propanedisulfonic acid
JP2009120598A5 (en)
WO2016172631A3 (en) Substrate selective inhibitors of insulin-degrading enzyme (ide) and uses thereof
ZA201503110B (en) Compositions, methods and uses for the treatment of diabetes and related conditions by controlling blood glucose level
PH12012501052A1 (en) Novel spiropiperidine compounds
WO2011147951A8 (en) Cycloamino derivatives as gpr119 agonists
PH12014502567A1 (en) Piperidine derivatives for gpr119 agonist
WO2012117000A8 (en) 3-amino-pyridines as gpbar1 agonists
WO2007125405A3 (en) Substituted 2-amino-fused heterocyclic compounds
CL2009000173A1 (en) Compounds derived from urea-tetrahydroxyquinoxaline; preparation procedure; intermediate compounds; pharmaceutical composition; and use for the treatment and prevention of obesity and diabetes, insulin resistance, metabolic syndrome, among others.
WO2009121939A3 (en) C-aryl glycoside compounds for the treatment of diabetes and obesity
WO2011127333A3 (en) Compounds for treating disease, for administering, and for pharmaceutical compositions
CL2014001437A1 (en) Compounds derived from aryl dihydropyridinone and piperidinone as inhibitors of monoacrylic glycerol acyltransferase (mgat2); pharmaceutical composition and combination; and use in the treatment and prevention of diabetes, hyperglycemia, retinopathy, metabolic syndrome, among other diseases.
EP2670368A4 (en) New oral dissolving films for insulin administration, for treating diabetes
PH12014502448A1 (en) Pharmaceutical combinations for the treatment of metabolic disorders
WO2011085643A8 (en) Fused pyridine derivatives
WO2011045232A3 (en) Neuropeptide-2 receptor (y-2r) agonists
WO2010052144A3 (en) Neuropeptide-2-receptor (y-2r) agonists and uses thereof
WO2013028818A8 (en) Pyrimido- pyridazinone compounds and use thereof
WO2014087307A3 (en) Compositions and methods for the treatment of metabolic syndrome and diabetes
WO2014080307A3 (en) Compositions and methods for the treatment of diabetes and pre-diabetes

Legal Events

Date Code Title Description
122 Ep: pct application non-entry in european phase

Ref document number: 13845363

Country of ref document: EP

Kind code of ref document: A2